{{Rsnum
|rsid=1805352
|Gene=RXRA
|Chromosome=9
|position=134408103
|Orientation=plus
|GMAF=0.4063
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=RXRA
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 53.6 | 42.9 | 3.6
| HCB | 50.7 | 44.1 | 5.1
| JPT | 59.3 | 36.3 | 4.4
| YRI | 9.2 | 44.0 | 46.8
| ASW | 10.7 | 41.1 | 48.2
| CHB | 50.7 | 44.1 | 5.1
| CHD | 56.0 | 37.6 | 6.4
| GIH | 21.8 | 50.5 | 27.7
| LWK | 4.6 | 44.0 | 51.4
| MEX | 33.3 | 54.4 | 12.3
| MKK | 0.0 | 0.0 | 0.0
| TSI | 42.0 | 49.0 | 9.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20145122
|Title=Genetic Polymorphisms in Vitamin D Receptor VDR/RXRA Influence the Likelihood of Colon Adenoma Recurrence
|OA=1
}}

{{PMID Auto
|PMID=18978339
|Title=Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}